Related Experiment Video
Updated: Feb 16, 2026

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse
Published on: December 16, 2022
Homocysteine, folate, and congenital heart defects
James C Huhta1, Jose A Hernandez-Robles
1University of South Florida College of Medicine, St. Petersburg, Florida 33701, USA. jhernand@hsc.usf.edu
Insights
Folic acid supplementation during early pregnancy may prevent congenital heart defects by managing homocysteine levels. This approach targets prevention for at-risk populations.
Area of Science:
- Cardiovascular Science
- Nutritional Science
- Developmental Biology
Background:
- Congenital heart disease (CHD) remains a significant public health concern.
- Periconceptional health and maternal nutrition are critical for fetal development.
- Homocysteine metabolism is increasingly recognized for its role in developmental processes.
Purpose of the Study:
- To explore the potential of folate supplementation in preventing congenital heart disease.
- To review the evidence linking maternal and fetal folate metabolism to cardiovascular malformations.
- To identify applications for managing at-risk populations for CHD.
Main Methods:
- Literature review of studies on folate metabolism, homocysteine, and congenital heart defects.
- Analysis of evidence connecting maternal and fetal biochemical pathways to cardiovascular development.
- Synthesis of findings for potential clinical applications.
Main Results:
- Evidence suggests a link between homocysteine levels and the development of congenital heart malformations.
- Folate supplementation may offer a viable strategy for periconceptional management.
- Understanding folate-homocysteine interactions is key to preventing certain CHDs.
Conclusions:
- Periconceptional folate supplementation represents a promising frontier for CHD prevention.
- Management of homocysteine and its metabolites is crucial for cardiovascular health during development.
- Targeted interventions in at-risk populations can potentially reduce CHD incidence.
Abstract:
Congenital heart disease will be the next frontier for prevention by periconceptional management of homocysteine and its metabolites by folate supplementation. Evidence for the connection between maternal and fetal folate metabolism and congenital malformations of the cardiovascular system is reviewed including possible applications to the large population of patients at risk for a child with congenital heart disease.
Related Concept Videos
Overview of the Heart
The heart's structure...
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Lumber Defects
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
Anatomy of the Heart
Anatomy of the Heart
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
Conduction System of the Heart
This system relies on the unique properties of nodal and Purkinje cells:...

